4.8 Article

Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma

Journal

GASTROENTEROLOGY
Volume 165, Issue 1, Pages 88-103

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2023.03.008

Keywords

Gastric Cancer; T-Cell State; CXCL13; Immune Checkpoint Blockade

Ask authors/readers for more resources

This study provides a detailed analysis of immune cell compositions and states in advanced gastric cancer patients using a single-cell profiling strategy. The findings reveal that gastric signet-ring cell carcinoma (GSRCC) exhibits a quiescent tumor immune microenvironment (TIME), leading to impaired functions of B cells and CD4+ and CD8+ T cells. CXCL13, a central coordinator, plays a crucial role in this transformation. The study also demonstrates that CXCL13 expression can serve as a predictor for the response to immune checkpoint blockade in gastric cancer patients.
BACKGROUND & AIMS: Gastric cancer (GC) is a major cancer type characterized by high heterogeneity in both tumor cells and the tumor immune microenvironment (TIME). One intractable GC subtype is gastric signet-ring cell carcinoma (GSRCC), which is associated with poor prognosis. However, it remains unclear what the GSRCC TIME characteristics are and how these characteristics may contribute to clinical outcomes.METHODS: We enrolled 32 patients with advanced GC of diverse subtypes and profiled their TIME using an immune targeted single-cell profiling strategy, including (1) immune targeted single-cell RNA sequencing (n = 20 patients) and (2) protein expression profiling by a targeted antibody panel for mass cytometry (n = 12 patients). We also generated matched V(D)J (variable, diversity, and joining gene segments) sequencing of T and B cells along CD45+ immunocytes.RESULTS: We found that compared to non-GSRCC, the GSRCC TIME appears to be quiescent, where both CD4+ and CD8+ T cells are difficult to be mobilized, which further impairs the proper functions of B cells. CXCL13, mainly produced by follicular helper T cells, T helper type 17, and exhausted CD8+ T cells, is a central coordinator of this transformation. We show that CXCL13 expression can predict the response to immune checkpoint blockade in GC patients, which may be related to its effects on tertiary lymphoid structures.CONCLUSIONS: Our study provides a comprehensive molecular portrait of immune cell compositions and cell states in advanced GC patients, highlighting adaptive immune irresponsiveness in GSRCC and a mediator role of CXCL13 in TIME. Our targeted single-cell transcriptomic and proteomic profiling represents a powerful approach for TIME-oriented translational research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available